Aspen CEO Stephen Saad (L) and South Africa Minister of Trade Ebrahim Patel
Riding Covid-19 high, Aspen plans new additions at South African production site
Changes are coming to Aspen Pharmacare’s plant in Gqeberha, South Africa.
The company will open the largest anesthetics manufacturing line in the southern hemisphere at the same site that it fills and packages the J&J Covid-19 vaccine, the company’s CEO Stephen Saad told reporters Monday.
The expansion could generate another $542 million in revenue a year. In 2018, Aspen started manufacturing drugs for late-stage cancer, autoimmune illnesses and Parkinson’s disease. Just last year, it started fill-finish operations for the J&J jab.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters